MedPath

Acute and Long Term Effects of VNS on Memory in Patients With Refractory Epilepsy

Not Applicable
Completed
Conditions
Refractory Epilepsy
Interventions
Diagnostic Test: Memory task
Registration Number
NCT05031208
Lead Sponsor
University Hospital, Ghent
Brief Summary

Refractory epilepsy patients implanted with a vagus nerve stimulator perform a memory test at baseline in three conditions: invasive vagus nerve stimulation (VNS), transcutaneous vagus nerve stimulation (taVNS) and sham stimulation. After 6 weeks of VNS treatment, the memory test is repeated in two condition: invasive vagus nerve stimulation (VNS) and sham stimulation.

The endpoint of this experiment is assessing the effect of VNS and taVNS on memory performance.

Detailed Description

Previous studies underlined the potential of both invasive as transcutaneous auricular vagus nerve stimulation to ameliorate certain cognitive functions.

In this randomized, controlled cross-over within-subjects study, a memory test is conducted in patients with refractory epilepsy who are implanted with a vagus nerve stimulation.

The memory test consists out of a word recognition paradigm based on the study of Clarck et al. published in 1999 in Nature Neuroscience. Testing is performed at baseline (before start of the stimulation) and after 6 weeks of treatment with vagus nerve stimulation.

During the first session, the patients complete the word recognition task during three interventions:

* Invasive vagus nerve stimulation

* Transcutaneous vagus nerve stimulation (cymba concha)

* Sham vagus nerve stimulation (no stimulation)

During the second session, the patients complete the word recognition task during two interventions:

* Invasive vagus nerve stimulation

* Sham vagus nerve stimulation (no stimulation)

The goal is to investigate if invasive vagus nerve stimulation and transcutaneous nerve stimulation can influence (i.e. improve) the performance on the memory task and if this performance is improved after 6 weeks of VNS treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Refractory epilepsy
  • Treated with vagus nerve stimulation
  • IQ >= 70 and able to perform the memory task
Exclusion Criteria
  • IQ < 70

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Transcutaneous vagus nerve stimulationMemory taskCymba concha stimulation
Sham vagus nerve stimulationMemory taskNo vagus nerve stimulation
Vagus nerve stimulationMemory taskInvasive vagus nerve stimulation
Primary Outcome Measures
NameTimeMethod
Delayed recognition scores at session 1At baseline

Hitscore for correctly recognized target words (min score 0,max score 63, higher score indicates better performance), score for not recognized target words= misses (min score 0,max score 63, higher score indicates worse performance),correct rejection score of non-target related words (min score 0,max score 63, higher score indicates better performance), score for incorrect recognition of non-target related words= false alarms (min score 0,max score 63, higher score indicates worse performance), discrimination index= hit score -false alarm score (min score 0,max score 63, higher score indicates better performance). All scores are calculated as a percentage.

Delayed recognition scores at session 2After 6 weeks of VNS treatment

Hitscore for correctly recognized target words (min score 0,max score 48, higher score indicates better performance), score for not recognized target words= misses (min score 0,max score 48, higher score indicates worse performance),correct rejection score of non-target related words (min score 0,max score 48, higher score indicates better performance), score for incorrect recognition of non-target related words= false alarms (min score 0,max score 48, higher score indicates worse performance), discrimination index= hit score -false alarm score (min score 0,max score 48, higher score indicates better performance). All scores are calculated as a percentage.

Immediate recall score at session 1At baseline

Free recall score for correctly recalled words (min score 0,max score 21, higher score indicates better performance), calculated as a percentage

Immediate recall score at session 2After 6 weeks of VNS treatment

Free recall score for correctly recalled words (min score 0, max score 21, higher score indicates better performance)), calculated as a percentage

Secondary Outcome Measures
NameTimeMethod
Attention score at session 2After 6 weeks of VNS treatment

Score of correct responses on 6 open question (min score 0, max score 6, higher score indicates better performance), calculated as a percentage

Attention score at session 1At baseline

Score of correct responses on 6 open question (min score 0, max score 6, higher score indicates better performance), calculated as a percentage

Trial Locations

Locations (1)

University Hospital

🇧🇪

Ghent, Belgium

© Copyright 2025. All Rights Reserved by MedPath